Areglo, Thery S.

HRN: 28-69-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/15/2026
03/21/2026
IV
224mg
Q8
Intraabdominal Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: